The effect of soy peptide intake on sarcopenia and cognitive decline: A randomized controlled trial

The effect of soy peptide intake on sarcopenia and cognitive decline: A randomized controlled trial - The effect of soy peptide intake on physical and cognitive functions

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000044966

Enrollment

Registered

2021-08-05

Start date

2018-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subject

Interventions

Intervention group: soy peptide containing drink 190g, 3 months Control group: non-intake of soy peptide containing drink

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Elderly adults who have participated in cohort studies 2. Independent person in their activities of daily living and do not utilize Japan's long-term care service

Exclusion criteria

Exclusion criteria: 1. Patient with dementia 2. Patient with severe cardiac, pulmonary, neurological or musculoskeletal disorders 3. Patient with food, and/or specifically soy allergy

Design outcomes

Primary

Measure	Time frame
Number of correct answers on nueropsychological tests skeletal muscle index grip strength Timed & Up Go Test	—

Secondary

Measure	Time frame
Blood parameter	—

Countries

Japan

Contacts

Public ContactItsushi Takai

Osaka University of Economics Department of Human Sciences

takai@osaka-ue.ac.jp06-6328-2431

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026